- No serious concerns in the Phase II trial92- Theoretical risk of fibrotic stricturing disease, attributable to the role of TGF-β1 in collagen synthesis, extracellular matrix dynamics, and fibrogenesis. However, no patient developed small bowel strictures in a 6-month phase I study91. Here, TGFB1 is linked to glycogen storage disease VI.